9 Meters Biopharma, Inc. NMTR
Set alert
0.07 0.00 0.00%
At close · Jul 25
0.0715 Day range 0.1127
52-week range unavailable
- Open
- 0.1103
- Prev close
- 0.0722
- Mkt cap
- 1.04M
- Vol
- 4.59M
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.0715
- High
- 0.1127
- Forward P/E
- -0.27
- Beta
- 1.48
- Short ratio
- 7.78
- Inst. own
- 16.43%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 21, 2023
- 50-d avg
- 0.7188
- 200-d avg
- 1.73
- 1y target
- 10.38
YTD chart
Events in this range
- Feb 13, 2023Rating: Citigroup · — → Neutral
- Mar 20, 2023Downgrade: Truist Securities · Buy → Hold
- Mar 28, 2023Earnings: —; estimate -0.8; surprise —%
- May 15, 2023Earnings: —; estimate -0.79; surprise —%
- May 18, 2023Rating: Citigroup · Neutral → Neutral
- Jun 1, 2023Rating: Citigroup · Neutral → Neutral
Signals (14)
| Name | Date | Ago |
|---|---|---|
| MACD: Sell Signal | Jul 18, 2023 | 3 years ago |
| RSI: Oversold | Jul 18, 2023 | 3 years ago |
| MACD: Buy Signal | May 12, 2023 | 3 years ago |
| RSI: Oversold | May 11, 2023 | 3 years ago |
| MACD: Sell Signal | Apr 24, 2023 | 3 years ago |
| RSI: Oversold | Apr 24, 2023 | 3 years ago |
| MACD: Buy Signal | Mar 27, 2023 | 3 years ago |
| RSI: Oversold | Mar 10, 2023 | 3 years ago |
| SMA: Bearish | Feb 22, 2023 | 3 years ago |
| MACD: Sell Signal | Feb 13, 2023 | 3 years ago |
| MACD: Buy Signal | Feb 6, 2023 | 3 years ago |
| MACD: Sell Signal | Jan 27, 2023 | 3 years ago |
| RSI: Overbought | Jan 5, 2023 | 3 years ago |
| SMA: Bullish | Jan 4, 2023 | 3 years ago |
Discussion (40)
Sign in to join the discussion
NOT FINANCIAL ADVICE
No one wants to sell this thing at 1.20ish??? Wtffff
LETSSS GOOO
I don’t understand how this is not moving… ITS ONLY one dollar a share!!!
$CBDL is ripping, again!!! ?
$CBDL is primed and ready for take off ?
Keep climbing! I want to see $3 this week!
Where are you all mother fucker’s with your ?, with your “tomorrow to the moon”, WHERE ARE YOU TODAY ???? Fucking assholes dick sucker.
FUCK YOU ALL
Oppenheimer appears to have put a buy and $6 target as per Benzinga